Roche Venture Fund

MISSION Therapeutics develops therapies that enhance the removal of dysfunctional mitochondria to combat serious diseases.

Cour Pharmaceuticals Development is developing nanoparticle technology to help reset the immune system of multiple sclerosis (MS) patients.

GlycoEra is a CustomGlycanengineering platform that unlocks the glycan-mediated biology to develop a pipeline of novel therapeutics.

NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.

Aligos Therapeutics is discovering and developing new classes of molecules that interact directly with disease-causing modalities.

Mironid is a drug discovery company focused on therapeutics for degenerative kidney diseases, chronic inflammatory diseases, and cancer.

DiogenX is a preclinical stage biotech company specializing in the development of pancreatic beta-cell modulators.

Bonum Therapeutics creates a technology platform to treat a wide range of diseases.

NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.

Good Therapeutics develops new technology for self-regulating drugs that will provide a therapeutic activity when, where it is needed.